Cash & equivalents increased 94.9%
Cash & equivalents changed +94.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +94.9% from the comparable as-filed period.
Gross margin changed +276 basis points from the comparable as-filed period.
Net income changed +19.4% from the comparable as-filed period.
Operating income changed +19.3% from the comparable as-filed period.
Operating margin changed +368 basis points from the comparable as-filed period.
Stock-based compensation changed +31.6% from the comparable as-filed period.
Gross profit changed +7.0% from the comparable as-filed period.
Inventory changed +9.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -4.3% from the comparable as-filed period.
Revenue changed -1.0% from the comparable as-filed period.
Selling, general & administrative changed +3.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.